Skip to main content

Elopag 20 mg ( Eltrombopag)

Understanding who manufactures a medicine is an important part of making informed decisions about pharmaceutical products. Patients, caregivers and healthcare professionals may want to know which company produces a medicine, where it is manufactured, who is responsible for its quality and which regulatory authority oversees its supply.

Elopag is identified on this website as a product containing eltrombopag 20 mg. However, the specific manufacturer, marketing authorization holder and manufacturing location for the Elopag product have not been independently confirmed from the product documentation available for this page. For that reason, this website does not attribute Elopag to a particular pharmaceutical company without reliable supporting evidence.

This page explains the importance of manufacturer identification, the different roles involved in pharmaceutical production and the information that should be checked when evaluating an Elopag product.

Who Manufactures Elopag?

The manufacturer of the specific Elopag 20 mg product requires verification against its original packaging, official product leaflet or other reliable pharmaceutical documentation.

A medicine’s brand name does not always identify the company that physically manufactures it. In some cases, one company owns or markets a brand while another company produces the tablets under a manufacturing agreement. A separate company may also hold the marketing authorization or distribute the product in a particular country.

For this reason, it is important to distinguish between the following roles:

  • Product manufacturer: The company or manufacturing facility responsible for producing the finished medicine.
  • Marketing authorization holder: The company or legal entity responsible for the product’s authorization in a particular market.
  • Brand owner: The company that owns or manages the commercial brand name.
  • Distributor: The company responsible for supplying the product through a distribution network.
  • Active ingredient developer: The organization involved in discovering or developing the medicine’s active pharmaceutical ingredient.

These roles may belong to one company or several different organizations. They should not be treated as interchangeable.

Understanding Eltrombopag

Eltrombopag is the active pharmaceutical ingredient identified for Elopag on this website. It belongs to a class of medicines known as thrombopoietin receptor agonists.

Eltrombopag acts on the thrombopoietin receptor, also known as c-Mpl, which plays a role in the production of platelets. By stimulating this receptor, eltrombopag can increase platelet production in selected patients with certain medical conditions.

Eltrombopag is used in specific treatment settings, including certain patients with chronic immune thrombocytopenia and severe aplastic anemia. It may also be used in selected patients with thrombocytopenia associated with chronic hepatitis C in treatment contexts covered by applicable prescribing information.

The exact approved uses, patient eligibility, treatment duration and monitoring requirements depend on the applicable product label and national regulatory authorization. A healthcare professional must determine whether eltrombopag is appropriate for an individual patient.

The identity of the active ingredient does not, by itself, establish the manufacturer or regulatory status of a particular branded product.

Why Manufacturer Information Matters

Manufacturer information is an important part of pharmaceutical product identification. It helps patients and healthcare professionals determine where a medicine comes from and which organization is responsible for its production.

Reliable manufacturer information can help with:

Product identification: The manufacturer’s name helps distinguish one product from another, particularly when different companies supply medicines containing the same active ingredient.

Quality responsibility: Pharmaceutical manufacturers are expected to follow applicable manufacturing standards and quality-control requirements. Product documentation helps identify the organization responsible for the finished medicine.

Regulatory verification: A product may need authorization or registration before it can be legally marketed in a particular country. Manufacturer and authorization details can help users check the relevant regulatory record.

Product complaints: If packaging is damaged, tablets appear unusual or a suspected quality problem occurs, manufacturer and batch details can help the appropriate organization investigate the issue.

Supply-chain transparency: Identifying the manufacturer, marketing authorization holder and distributor can help clarify the different organizations involved in supplying a medicine.

Manufacturer information should therefore be obtained from reliable documentation rather than assumptions based on a brand name or active ingredient.

How to Verify the Manufacturer of Elopag

Before relying on manufacturer information, check the product’s original packaging and official documentation. The following details can help establish the identity of a pharmaceutical product.

1. Check the outer packaging

Look for the manufacturer’s name and address printed on the carton. Some packaging may also identify the marketing authorization holder, importer or distributor.

The wording should be read carefully because these organizations may have different responsibilities.

2. Review the package leaflet

The official patient information leaflet or package insert may identify the manufacturer and provide information about the product’s composition, approved uses, administration and safety precautions.

The leaflet should correspond to the exact product and market.

3. Confirm the active ingredient and strength

Check whether the product documentation identifies eltrombopag as the active ingredient and confirms the stated 20 mg strength.

Do not rely only on the appearance of a tablet or the brand name printed in an advertisement.

4. Check batch and expiry information

The packaging should include appropriate batch or lot identification and an expiry date. These details are important for traceability and quality-related inquiries.

5. Review applicable regulatory records

Where available, consult the medicines regulatory authority responsible for the country in which the product is marketed. Check whether the product name, manufacturer and authorization information match the packaging.

6. Ask a pharmacist or authorized supplier

A qualified pharmacist or legitimate pharmaceutical supplier may be able to help confirm product identity and explain which documentation is available.

If the information cannot be verified, do not assume that the product is authentic or authorized.

Manufacturer and Product Quality

Pharmaceutical manufacturing involves more than producing tablets with a particular active ingredient. It includes controls over raw materials, manufacturing processes, testing, packaging, storage and distribution.

Quality systems are intended to help ensure that medicines consistently meet applicable specifications. These may include requirements concerning identity, strength, purity, dissolution, stability and contamination control.

Good Manufacturing Practice, commonly known as GMP, is a framework used by pharmaceutical regulators to help ensure that medicines are consistently produced and controlled according to appropriate quality standards.

However, a website should not claim that a particular Elopag product or manufacturing facility is GMP-certified, inspected or approved unless documentary evidence supports that statement. Any certification or regulatory claim should be checked against the relevant authority and should apply to the correct company, facility and product.

Elopag Product Information and Manufacturer Transparency

The product information presented on this website identifies Elopag as containing eltrombopag in a stated 20 mg strength. This description should not be interpreted as independent confirmation of the product’s manufacturer, country of origin, regulatory authorization or manufacturing standards.

The following product-specific details require confirmation from reliable documentation:

Product detailVerification status
Brand nameElopag
Active ingredientEltrombopag
Stated strength20 mg
Finished-product manufacturerNot independently verified
Manufacturing locationNot independently verified
Marketing authorization holderNot independently verified
Country-specific registrationRequires verification
Product-specific GMP documentationRequires verification

This distinction is important because general information about eltrombopag cannot establish the identity or regulatory status of every product sold under a particular brand name.

Responsible Use of Manufacturer Information

Manufacturer details are useful for product identification, but they do not determine whether a medicine is suitable for a particular patient.

Eltrombopag treatment requires professional supervision. Depending on the patient’s condition and applicable prescribing information, monitoring may include platelet counts, liver function tests and assessment of treatment response.

Patients should not start, stop or change eltrombopag treatment based on manufacturer information or general website content. The medicine should be used only under the direction of an appropriately qualified healthcare professional.

If a product’s packaging, manufacturer details or source appear inconsistent, seek advice from a pharmacist or relevant medicines regulatory authority before using it.

Our Commitment to Accurate Product Information

This website aims to present clear and responsible information about Elopag and eltrombopag. Product-specific statements should be supported by reliable documentation, and information that has not been confirmed should be identified as requiring verification.

We do not claim that a particular company manufactures Elopag unless the relevant product documentation establishes that relationship. We also do not imply that the product has a specific regulatory approval, certification or manufacturing origin without supporting evidence.

Accurate manufacturer information is important for patient awareness, product traceability and responsible pharmaceutical communication.

Frequently Asked Questions

Who is the manufacturer of Elopag 20 mg?

The manufacturer of the specific Elopag 20 mg product has not been independently verified from the documentation available for this page. Check the original packaging and official product leaflet for the manufacturer’s name and address.

Does Elopag contain eltrombopag?

Elopag is identified on this website as a product containing eltrombopag in a stated 20 mg strength. The actual product packaging and leaflet should be checked to confirm its composition.

Is the manufacturer the same as the distributor?

Not necessarily. The manufacturer produces the finished medicine, while a distributor supplies it through a commercial or pharmaceutical distribution network. A marketing authorization holder may be a separate organization.

Who developed eltrombopag?

The developer of an active pharmaceutical ingredient and the manufacturer of a particular branded product are not necessarily the same company. Product-specific manufacturer details should be verified separately from the medicine’s development history.

How can I confirm that Elopag is authentic?

Check the original packaging, manufacturer details, batch number, expiry date and applicable regulatory information. A pharmacist or medicines regulatory authority may help assess whether the documentation is consistent.

Does the manufacturer’s name prove that a medicine is safe?

No. A company name alone does not prove that a medicine is authentic, appropriately stored or suitable for a particular patient. Product verification and professional medical guidance remain important.

Important Medical Disclaimer

This page provides general educational information about pharmaceutical manufacturing and product identification. It does not provide medical advice, diagnose a condition or recommend treatment.

Eltrombopag is a prescription medicine that requires appropriate medical supervision. Patients should consult their healthcare professional and follow the official prescribing information applicable to their country.

Manufacturer statement: The specific manufacturer of Elopag has not been independently confirmed for this page. This information should be updated only when reliable product documentation becomes available.